Skip to content

Aripiprazole D8

Aripiprazole D8

Product Description
CAT No.
ALN-A001D01
CAS No.
1089115-04-7
Mol. F.
C23H19D8Cl2N3O2
Mol. Wt.
456.4
Stock
Please Inquire
RFQ
Chemical Name : 7-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butoxy-1,1,2,2,3,3,4,4-d8)-3,4-dihydroquinolin-2(1H)-one
Smiles : O=C1NC2=CC(OC([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])N3CCN(C(C=CC=C4Cl)=C4Cl)CC3)=CC=C2CC1
Inchi : InChI=1S/C23H21F7N4O3/c1-12(14-8-15(22(25,26)27)10-16(9-14)23(28,29)30)37-20-19(13-2-4-17(24)5-3-13)34(6-7-36-20)11-18-31-21(35)33-32-18/h2-5,8-10,12,19-20H,6-7,11H2,1H3,(H2,31,32,33,35)/t12-,19+,20-/m1/s1/i2D,3D,4D,5D

Formulation of aripiprazole-loaded pH-modulated solid dispersions via hot-melt extrusion technology: In vitro and In vivo studies

Haley McFall1 , Sandeep Sarabu1 , Vijaykumar Shankar1 , Suresh Bandari1 , S. Narasimha Murthy1 , Karl Kolter2 , Nigel Langley3 , Dong Wuk Kim4**, Michael A. RepkanInternational Journal of Pharmaceutics Volume 554, 10 January 2019, Pages 302-311

Molecular determinants of the intrinsic efficacy of the antipsychotic aripiprazole

Identification of Degradation Impurities in Aripiprazole Oral Solution Using LC-MS and Development of Validated Stability Indicating Method for Assay and Content of Two Preservatives by RP-HPLC

, Michael A. Repka – International Journal of Pharmaceutics Volume 554, 10 January 2019, Pages 302-311

Request For Quotation

Related Products